# Renalof in the Treatment of Elderly Patients With Gallstones

> **NCT01099319** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 40 (actual)

## Conditions studied

- Cholelithiasis

## Interventions

- **DIETARY_SUPPLEMENT:** Renalof
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01099319
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01099319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01099319, "Renalof in the Treatment of Elderly Patients With Gallstones". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01099319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*